Please login to the form below
Cohn & Wolfe launch legal action
It has been reported that PR agency, Cohn & Wolfe is to begin legal proceedings against two former members of staff
Cohn & Wolfe is to launch legal proceedings against two former members of staff, dismissed from the agency last week.
According to reports, it is alleged that Fiona McMillan and Rebecca Galbraith, who resigned from the agency in December and were working out their notice periods, were dismissed last week for gross misconduct.
McMillan and Galbraith are reported to strongly deny any wrongdoing.
Cohn & Wolfe UK CEO Fiona Noble is said to have confirmed that 'solicitors have been retained by all parties involved, letters before action have been sent to them and legal proceedings are being prepared'.
Speaking to PR Week, Noble said: "We are taking legal action to obtain orders from the High Court requiring Fiona and Rebecca to act lawfully and in compliance with their Cohn & Wolfe employment contracts".
Cohn & Wolfe declined the opportunity to provide any further comments to PMLiVE.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Manager (PR)
-
Great Benefits
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- MHRA raises concerns over fraudulent coronavirus tests
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- Novartis donates malaria drug for COVID-19 clinical trials
- Making a difference with patient support
- Servier agrees to buy Symphogen to swell its cancer pipeline
- A Renewed Love of the NHS and National Recovery of the Patient-Doctor Relationship
- GSK and Vir Biotech join forces for COVID-19 antibodies
- Coronavirus causes Cancer Research UK to slash funding by £44m
- EMA backs compassionate use of Gilead’s remdesivir for COVID-19
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- What challenges still face clinical trial recruitment and retention?
- Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Quick links
Infographics
